Dare Bioscience Inc (DARE)

[9HikeDiscGolf]

Investors Alert: Cerulean Pharma Inc.’s (CERU) stock price is now Worth at $0.69
March 28, 2017 Robert Ebelling 0 Comment CERU, Cerulean Pharma Inc.

Cerulean Pharma Inc. (CERU)’s Stock Price Update:

Cerulean Pharma Inc. (CERU) stock price ended its day with loss -4.81% and finalized at the price of $0.69. During its last trading session, Stock traded with the total exchanged volume of 2.08 million shares. The average volume stands around 3.85 million shares. The average numbers of shares are traded in a security per day, during the recent 3-month period. The stock has relative volume of 0.54. Relative volume is ratio between current volume and 3-month average value, intraday adjusted. Cerulean Pharma Inc. (CERU) is a part of Healthcare sector and belongs to Biotechnology industry.

ATR value of company was 0.38. Average True Range (ATR) is an indicator based on trading ranges smoothed by an N-period exponential moving average percentage of the true range values. ATR can display volatility of stocks, ETFs and indexes. The principal of ATR is very similar to other volatility indicators: A high ATR value signals a possible trend change. A low ATR value correlates with a weaker trend movement.

USA based company, Cerulean Pharma Inc. (CERU)’s latest closing price distance was -49.69% from the average-price of 200 days while it maintained a distance from the 50 Day Moving Average at -46.86% and -58.09% compared with the 20 Day Moving Average.

To review the CERU previous performance, look at its past history, which highlighted below:

During last 5 trades the stock sticks almost -44.80%.

During last one month it showed the change of -44.80%.

During last 3 month it remained at -10.40%.

During last 12 month it moved at -73.15%.

Along with these its year to date performance is standing at -2.57%.

Relative Strength Index (RSI) was 38.52. The stock volatility for week was 17.96% while for month was 17.20%.The stock, as of last close, traded 9.47% to its 52 week low and was changed -84.06% from its 52 week high. CERU’s value Change from Open was at -1.43% with a Gap of -3.43%.

EPS growth in next year is estimated to reach 3.30% while EPS growth estimate for this year is set at 3.00%.

Analysts’ mean recommendation for Cerulean Pharma Inc. (CERU) stands at 2.30. Rating Scale; where 1.0 rating means Strong Buy, 2.0 rating signify Buy, 3.0 recommendation reveals Hold, 4.0 rating score shows Sell and 5.0 displays Strong Sell signal.


http://www.hotstockspoint.com/investors-alert-cerulean-pharma-inc-s-ceru-stock-price-is-now-worth-at-0-69/